P/E at 60.59 vs Industry's 65.95: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Discount?

The current P/E of Apollo Hospitals Enterprise Ltd. at 60.59 is approximately 8.1% lower than the industry average of 65.95. This suggests that despite its large-cap stature and strong market presence, the stock trades at a modest discount relative to its hospital sector peers. Such a valuation gap could reflect investor caution or a recognition of the company's specific growth prospects and risk profile. The sector's elevated P/E indicates generally high expectations for earnings growth, yet Apollo Hospitals appears to be priced with a slightly more conservative outlook. What factors might be influencing this valuation gap?

Performance Across Timeframes: Momentum and Consistency

Examining the stock's returns reveals a consistent outperformance relative to the Sensex across multiple timeframes. Over one year, Apollo Hospitals gained 12.98%, while the Sensex declined by 4.68%. The year-to-date return is even more impressive at 25.48%, contrasting sharply with the Sensex's 9.10% loss. The three-month return of 10.18% also surpasses the Sensex's 2.86%, indicating sustained positive momentum in the medium term. Shorter-term performance shows a more muted picture, with a 0.18% gain over one month and a 0.99% rise over one week, both outperforming the Sensex's negative returns in those periods. The stock's one-day performance was a slight decline of 0.32%, marginally better than the Sensex's 0.34% fall.

Despite this generally positive trend, the stock has experienced a two-day consecutive fall, losing 1.38% in that span. This short-term weakness may reflect profit-taking or sector-specific pressures. Is this a temporary correction or indicative of a broader shift in momentum? The data suggests that while the stock remains resilient, investors should monitor near-term developments closely.

Moving Average Configuration: Technical Insights

The technical setup of Apollo Hospitals Enterprise Ltd. offers further insight into its price dynamics. The stock currently trades above its 5-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength and a generally bullish trend over short to long-term horizons. However, it remains below its 20-day moving average, suggesting some recent resistance or consolidation in the near term. This configuration often points to a recovery phase within a larger uptrend, where short-term momentum is temporarily subdued but longer-term support remains intact. The 5% surge partially reverses a 6.45% monthly decline — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context

The hospital sector has shown mixed results recently, with a blend of positive, flat, and negative performances among its constituents. Apollo Hospitals stands out with its consistent outperformance relative to the Sensex and many peers. Its large-cap status and market cap of ₹1,27,068.25 crores underpin its leadership position in the sector. The sector's average P/E of 65.95 reflects elevated growth expectations, yet Apollo Hospitals trades at a slight discount, which may indicate a more measured valuation approach by investors.

Rating Reassessment and Historical Performance

Previously rated Buy by MarketsMOJO, Apollo Hospitals Enterprise Ltd. had its rating updated on 14 Aug 2026. While the current rating is not disclosed, the reassessment reflects a comprehensive review of the company's fundamentals, valuation, and technicals. The stock's long-term performance is notable, with three-year returns of 82.53%, five-year returns of 84.62%, and an impressive ten-year return of 531.54%, all significantly outperforming the Sensex over the same periods. This track record underscores the company's sustained growth and resilience in a competitive sector. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: What the Data Collectively Shows

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest discount to its sector's elevated valuation. Its consistent outperformance relative to the Sensex across multiple timeframes, combined with a technical setup that suggests underlying strength despite short-term resistance, highlights a stock with solid momentum and resilience. The rating reassessment from Buy to a new grade reflects a nuanced view of its valuation and performance metrics. Investors analysing this stock should consider how the valuation premium or discount aligns with their risk appetite and investment horizon, especially given the sector's mixed performance backdrop. What is the current rating for Apollo Hospitals Enterprise Ltd. following this reassessment?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →